u/dose_creep_dan

going back and rolling-averaging my own data now, mildly annoyed at past me

respect the six weeks. I did the label pace and regretted it by week 3.

Cosigning on fertility changing with weight loss. It catches people who were not expecting it at all.

honestly for me it was just impatience dressed up as reasoning, in hindsight I hadn't ruled anything out, I just wanted the number to move faster

yeah in hindsight four weeks of flat scale is nothing, I panicked

went up because the scale stalled, not because i needed to, and the stall broke two weeks later at the higher dose so i will never know which it was. edit: which is its own small punishment.

...I have not been hitting my protein target in weeks if I'm honest, was assuming appetite being low meant everything was proportionally lower

noted, checking that too before I consider anything else

yeah this doesn't feel like the same thing as my old week-4 panic, this one's been genuinely flat by every measure I have

that's a fair correction actually, rereading my own post I did lean harder into "it was the water" than my own uncertainty supports. editing my framing mentally, thank you.

you were, and I want to be clear I saw the comment and just didn't take it seriously enough at the time, that's on me not on the advice being buried

wish I'd had this table three months ago before I panic-upped my dose over what was, in hindsight, entirely noise

this is exactly the distinction I didn't have when I panic-upped my own dose, mine was a week 8 stall and I treated it like a week 4 one

the first four weeks are a tolerance check, not a weight-loss phase

This is the part I would underline for anyone skimming. Everything else in the thread is downstream of it.

Adding the practical note — the formula is published and you can reproduce the ordering yourself.

Disagreeing with this bit: making individual cases public by default is worse for the person being moderated.

The same dose genuinely feels different at different points in the month for me. Took a year to notice and it was in the log the whole time.

Perimenopause and all of this at once, and there is essentially nothing written about the combination anywhere.

This. Anything involving pregnancy or contraception goes to a clinician, and this board should keep saying so.

Read the primary paper after arguing about the summary for a fortnight. The discussion section said almost the opposite of what the thread had concluded.

Steady state after a dose change takes four to five half-lives, so the fair judgement point on a new step is about a month, not four days.

On the "everybody ends up at 2.4" claim, which comes up every few weeks.

The escalation schedule in the trials was designed to get people to a fixed study dose. Real use is not a trial. The dose that keeps your appetite quiet with side effects you can live with is the dose, and for a lot of people on this board that has been 0.5mg for a very long time.

The counter-argument, which is fair: some people genuinely do need the top of the range, and staying low out of caution costs them months. That is a conversation with someone who knows your history, not with us.

Not convinced by the retrospective reconstruction.

Disagreeing with this bit: daily weighing gives you noise and costs you something.

Small correction: 2.4mg is the maintenance ceiling on the label, not the starting maintenance dose. The distinction matters for anyone reading this later.

Hormonal variation across the cycle affects appetite, fluid retention and subjective symptom intensity independently of anything else, which is why an unannotated log can look mysterious.

the wiki is editable by anybody with standing on the site

Disagree — that is a general claim about absorption and the specific question needs a pharmacist rather than a board.

Are you asking about the compound, the weight loss, or both?

incretin effect first, then everything else in this board makes sense

Not convinced by the linearity assumption. Dose-response in this class is not linear and the trials show it.

a log with no dates is a story

2.4 is a ceiling, not a target

Correction: that is glucose-dependent insulin secretion, which is why hypoglycaemia risk is low as monotherapy. Not the same claim as you made.

Correction: that trial did not enrol the population being discussed, so it cannot support the claim.

Went looking for human data on a mechanism everybody here asserts. Found preclinical work and one small study. That was clarifying.

The escalation schedule in the trials existed to keep people on the drug. It is a tolerability ramp, and it is why the label reads the way it does.

Do sulphur burps track the day after the shot, or is it there all week?

STEP-1 ran 68 weeks and landed just under 15% mean body weight change on 2.4mg. It is an average of a wide distribution, not a target you have missed.

Push back: the ranking is not hiding anything. The formula is published and you can reproduce the ordering.

dose day drift of a day either way is fine, the curve barely notices

cycle timing changes how the same week feels